Microbix Biosystems Stock Today
| MBXBF Stock | USD 0.22 0.01 4.76% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Microbix Biosystems is trading at 0.22 as of the 19th of July 2025. This is a 4.76% up since the beginning of the trading day. The stock's lowest day price was 0.22. Microbix Biosystems has about a 33 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of April 2025 and ending today, the 19th of July 2025. Click here to learn more.
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada. The company has 138.45 M outstanding shares. More on Microbix Biosystems
Moving against Microbix OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Microbix OTC Stock Highlights
| President | Philip Casselli |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Microbix Biosystems [MBXBF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 33.04 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Microbix Biosystems's market, we take the total number of its shares issued and multiply it by Microbix Biosystems's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Microbix Biosystems classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 138.45 M outstanding shares.
Microbix Biosystems has accumulated about 14.16 M in cash with 3.47 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1.
Check Microbix Biosystems Probability Of Bankruptcy
Ownership AllocationMicrobix Biosystems maintains a total of 138.45 Million outstanding shares. Microbix Biosystems secures 13.45 % of its outstanding shares held by insiders and 1.08 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Microbix Ownership Details
Microbix Biosystems Risk Profiles
| Mean Deviation | 1.51 | |||
| Standard Deviation | 2.75 | |||
| Variance | 7.54 | |||
| Risk Adjusted Performance | (0.07) |
Microbix Stock Against Markets
Picking the right benchmark for Microbix Biosystems otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Microbix Biosystems otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Microbix Biosystems is critical whether you are bullish or bearish towards Microbix Biosystems at a given time. Please also check how Microbix Biosystems' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Microbix Biosystems without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Microbix Biosystems Corporate Management
Elected by the shareholders, the Microbix Biosystems' board of directors comprises two types of representatives: Microbix Biosystems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Microbix. The board's role is to monitor Microbix Biosystems' management team and ensure that shareholders' interests are well served. Microbix Biosystems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Microbix Biosystems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Luscher | VP Affairs | Profile | |
| James Currie | Chief Officer | Profile | |
| Christopher Lobb | Gen Officer | Profile | |
| Kenneth Hughes | Chief Officer | Profile |
Other Information on Investing in Microbix OTC Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.